SOAPware Learning CenterClinical Quality Measures User Guide (for 2011) Additional Measures (Choose 3 Additional Measures)NQF 0067 (Additional) Coronary Artery Disease (CAD): Oral Antiplatelet Therapy Prescribed for Patients with CAD

NQF 0067 (Additional) Coronary Artery Disease (CAD): Oral Antiplatelet Therapy Prescribed for Patients with CAD

Measure:  NQF 0067

Measure Title:  Coronary Artery Disease (CAD): Oral Antiplatelet Therapy Prescribed for Patients with CAD

Measure Description:  Percentage of patients aged 18 years and older with a diagnosis of CAD who were prescribed oral antiplatelet therapy.

*REQUIRED FOR MEANINGFUL USE (MU) ADDITIONAL CQM MEASURE: Click here to view Meaningful Use Criteria.

Quality Measure Documentation Workflow

In order for the Clinical Quality Measure report to generate, the following must be documented in the relevant patient's chart.

1. Patient’s must be 18 years of age or older and have at least one face-to-face encounter with the provider during the reporting period.

2.  A diagnosis of Coronary Artery Disease (CAD) (recorded by using any of the ICD9 codes listed below) in the Summary Active Problems or the encounter Assessment field:

410.00, 410.01, 410.02, 410.10, 410.11, 410.12, 410.20, 410.21, 410.22, 410.30, 410.31, 410.32, 410.40, 410.41, 410.42, 410.50, 410.51, 410.52, 410.60, 410.61, 410.62, 410.70, 410.71, 410.72, 410.80, 410.81, 410.82, 410.90, 410.91, 410.92, 411.0, 411.1, 411.81, 411.89, 412, 413.0, 413.1, 413.9, 414.00, 414.01, 414.02, 414.03, 414.04, 414.05, 414.06, 414.07, 414.8, 414.9, V45.81, V45.82

3.  In addition, the patient must have documentation that an antiplatelet therapy medications was prescribed.  This can be documented using one of the following methods:

(a) Inserting one of the following SMARText medications in either the Summary Medications field or encounter Medications field: Plavix, Ticlid, Aspirin.

OR

(b) Inserting the shortcut code "PQRIcadPLA" in the encounter Plan field will allow the user to insert a specific SMARText code that can be used to document for this measure. The encounter Plan field should include the following code to document this information: 4011F (Antiplatelet Therapy Prescribed).

(Note: 4011F-1P, 4011F-2P, 4011F-3P and 4011F-8P will not increase the numerator because they indicate that antiplatelet therapy was not prescribed).

Measurement Calculation Details

Numerator Calculation:

The numerator for this measurement is calculated based on the following:

1. The number of patients in the denominator that have documentation that an antiplatelet therapy medication was prescribed.  The numerator for this measure will increase if one of the following methods is used:

(a) Documenting one of the following SMARText Medications in the Summary Medications field or encounter Medications field: Plavix, Ticlid, Aspirin.

OR

(b)  Inserting the shortcut code "PQRIcadPLA" in the encounter Plan field will allow the user to insert the following code: 4011F (Antiplatelet Therapy Prescribed).

*Note: 4011F-1P, 4011F-2P, 4011F-3P, and 4011F-8P will not increase the numerator.

Denominator Calculation:

The denominator for this measurement is calculated based on the following:

1. The number of patients that were at least 18 years of age or older and have at least one face-to-face encounter with the provider during the reporting period.

2. And have a diagnosis of Coronary Artery Disease (CAD) in the Summary Active Problems field or the encounter Assessment field using one of the following ICD9 codes:

410.00, 410.01, 410.02, 410.10, 410.11, 410.12, 410.20, 410.21, 410.22, 410.30, 410.31, 410.32, 410.40, 410.41, 410.42, 410.50, 410.51, 410.52, 410.60, 410.61, 410.62, 410.70, 410.71, 410.72, 410.80, 410.81, 410.82, 410.90, 410.91, 410.92, 411.0, 411.1, 411.81, 411.89, 412, 413.0, 413.1, 413.9, 414.00, 414.01, 414.02, 414.03, 414.04, 414.05, 414.06, 414.07, 414.8, 414.9, V45.81, V45.82

Report Clinical Quality Measures to CMS/States

All of the items listed in the above steps need to be documented as structured data (as detailed above) in order to allow the user to capture the numerator, denominator and percentage for this quality measure.

For information on how to export the numerator, denominator and percentage for each Clinical Quality Measure, Click here.

For more information on reporting clinical quality measures, Click here.